<DOC>
	<DOCNO>NCT00999063</DOCNO>
	<brief_summary>This prospective , epidemiological , multi-centre , phase IV study , approximately 5,000 patient suffer upper gastrointestinal tract symptom . Each patient assess GERD GerdQ Thai Version .</brief_summary>
	<brief_title>Prevalence Gastroesophageal Reflux Disease ( GERD ) Patients With Upper Gastrointestinal Track ( GIT ) Symptoms Thailand</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<criteria>Provision inform consent prior study specific procedure Female male age least 18 year Patient must symptoms suggestive upper gastrointestinal tract symptom heart burn/ regurgitation Involvement planning /or conduct study ( applies AstraZeneca staff /or staff study site Participation clinical study ( exclude noninterventional study registry ) last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>GerdQ</keyword>
</DOC>